The authors observed that men with either a negative scan or PSMA-positive disease confined to the fossa had significantly higher three-year failure free survival rates compared to those with either pelvic nodal or distant metastatic disease [37]. The gene discussed is FOLH1; the disease is metastatic neoplasm.